Published in Biomed Res Int on February 11, 2014
Acute kidney injury by radiographic contrast media: pathogenesis and prevention. Biomed Res Int (2014) 0.93
Prevention of contrast-induced nephropathy through a knowledge of its pathogenesis and risk factors. ScientificWorldJournal (2014) 0.90
Renalase protects against contrast-induced nephropathy in Sprague-Dawley rats. PLoS One (2015) 0.88
Targeting HO-1 by Epigallocatechin-3-Gallate Reduces Contrast-Induced Renal Injury via Anti-Oxidative Stress and Anti-Inflammation Pathways. PLoS One (2016) 0.81
Magnolin protects against contrast-induced nephropathy in rats via antioxidation and antiapoptosis. Oxid Med Cell Longev (2014) 0.79
Impact of Iodinated Contrast on Renal Function and Hemodynamics in Rats with Chronic Hyperglycemia and Chronic Kidney Disease. Biomed Res Int (2016) 0.77
Preventive effect of oral nicorandil on contrast-induced nephropathy in patients with renal insufficiency undergoing elective cardiac catheterization. Heart Vessels (2016) 0.77
Hospital-acquired renal insufficiency. Am J Kidney Dis (2002) 7.90
Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis (2009) 6.99
Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation (2002) 4.99
Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol (2011) 3.14
NGAL is an early predictive biomarker of contrast-induced nephropathy in children. Pediatr Nephrol (2007) 2.99
Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease. Circulation (2007) 2.59
Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol (2005) 2.42
Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial. J Am Coll Cardiol (2006) 2.33
Contrast-induced nephropathy and long-term adverse events: cause and effect? Clin J Am Soc Nephrol (2009) 2.23
Contrast-induced acute kidney injury and clinical outcomes after intra-arterial and intravenous contrast administration: risk comparison adjusted for patient characteristics by design. Am Heart J (2013) 2.09
A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media. J Am Coll Cardiol (2006) 2.03
Urinary IL-18 and NGAL as early predictive biomarkers in contrast-induced nephropathy after coronary angiography. Nephron Clin Pract (2008) 2.03
Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials. Radiology (2009) 1.99
A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy. Nephrol Dial Transplant (2012) 1.94
Biomarkers in acute and chronic kidney disease. Curr Opin Nephrol Hypertens (2008) 1.81
Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. Kidney Int (1995) 1.74
Neutrophil-gelatinase-associated lipocalin and renal function after percutaneous coronary interventions. Am J Nephrol (2006) 1.69
Renal failure in 57 925 patients undergoing coronary procedures using iso-osmolar or low-osmolar contrast media. Kidney Int (2006) 1.65
An overview of drug-induced acute kidney injury. Crit Care Med (2008) 1.64
Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med (1989) 1.59
Pre-procedural glucose levels and the risk for contrast-induced acute kidney injury in patients undergoing coronary angiography. J Am Coll Cardiol (2010) 1.53
Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology (1993) 1.47
Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure. J Am Soc Nephrol (1995) 1.36
Experimental ischemia-reperfusion: biases and myths-the proximal vs. distal hypoxic tubular injury debate revisited. Kidney Int (2010) 1.27
Neutrophil gelatinase-associated lipocalin (NGAL) correlations with cystatin C, serum creatinine and eGFR in patients with normal serum creatinine undergoing coronary angiography. Nephrol Dial Transplant (2006) 1.26
Pathophysiologic features and prevention of human and experimental acute tubular necrosis. J Am Soc Nephrol (2001) 1.10
Effects of contrast media and mannitol on renal medullary blood flow and red cell aggregation in the rat kidney. Kidney Int (1996) 1.10
Reading between the (guide)lines--the KDIGO practice guideline on acute kidney injury in the individual patient. Kidney Int (2013) 1.10
Injection of low and iso-osmolar contrast medium decreases oxygen tension in the renal medulla. Kidney Int (1998) 1.03
Captopril for prevention of contrast-induced nephropathy in diabetic patients: a randomised study. Indian Heart J (2000) 1.03
Impact of renin-angiotensin-aldosterone blockade by angiotensin-converting enzyme inhibitors or AT-1 blockers on frequency of contrast medium-induced nephropathy: a post-hoc analysis from the Dialysis-versus-Diuresis (DVD) trial. Nephrol Dial Transplant (2009) 0.96
Contrast-induced acute kidney injury following coronary angiography: a cohort study of hospitalized patients with or without chronic kidney disease. Nephrol Dial Transplant (2013) 0.93
Characteristics of response of renal vascular bed to contrast media. Evidence for vasoconstriction induced by renin-angiotensin system. Invest Radiol (1971) 0.92
Prevention of radiocontrast-media-induced nephrotoxicity by the calcium channel blocker nitrendipine: a prospective randomised clinical trial. Nephrol Dial Transplant (1989) 0.90
Effect of administration route on the renal safety of contrast agents: a meta-analysis of randomized controlled trials. J Nephrol (2012) 0.89
Radiocontrast media cause dephosphorylation of Akt and downstream signaling targets in human renal proximal tubular cells. Biochem Pharmacol (2006) 0.89
The effect of prophylactic nifedipine on renal function in patients administered contrast media. Pharmacotherapy (1995) 0.88
Differential activation of signaling pathways by low-osmolar and iso-osmolar radiocontrast agents in human renal tubular cells. J Cell Biochem (2014) 0.87
Randomised prospective study on renal effects of two different contrast media in humans: protective role of a calcium channel blocker. Nephron (1990) 0.86
Renal vasoconstrictive response to contrast medium. The role of sodium balance and the renin-angiotensin system. J Lab Clin Med (1983) 0.86
Contrast medium-induced acute kidney injury: comparison of intravenous and intraarterial administration of iodinated contrast medium. J Vasc Interv Radiol (2011) 0.86
Angiotensin-converting enzyme inhibitors as a risk factor for contrast-induced nephropathy. Nephron Clin Pract (2006) 0.85
A role for calcium in radiocontrast-induced reductions in renal hemodynamics. Kidney Int (1985) 0.84
Structural changes in the renal proximal tubular cells induced by iodinated contrast media. Nephron (1997) 0.84
Contrast-induced acute kidney injury: how much contrast is safe? Nephrol Dial Transplant (2013) 0.84
Is angiotensin-converting enzyme inhibitor a contraindication for contrast-induced nephropathy prophylaxis? A review about its paradox. Cardiovasc Ther (2011) 0.83
Mechanism of the renal response to contrast medium in dogs. Decrease in renal function due to hypertonicity. Invest Radiol (1983) 0.80
No evidence for protective effects of nifedipine against radiocontrast-induced acute renal failure. Clin Nephrol (1988) 0.78
Vascular contributions to pathogenesis of acute renal failure. Ren Fail (1998) 0.76
Acute kidney injury by radiographic contrast media: pathogenesis and prevention. Biomed Res Int (2014) 0.93
Prevention of contrast-induced nephropathy through a knowledge of its pathogenesis and risk factors. ScientificWorldJournal (2014) 0.90
Current Tissue Molecular Markers in Colorectal Cancer: A Literature Review. Biomed Res Int (2017) 0.75
Diagnostic, Predictive, Prognostic, and Therapeutic Molecular Biomarkers in Third Millennium: A Breakthrough in Gastric Cancer. Biomed Res Int (2017) 0.75